nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CHRM2—Dimenhydrinate—atopic dermatitis	0.194	0.248	CbGbCtD
Fesoterodine—CHRM2—Diphenhydramine—atopic dermatitis	0.0948	0.121	CbGbCtD
Fesoterodine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0505	0.0645	CbGbCtD
Fesoterodine—ABCB1—Tacrolimus—atopic dermatitis	0.0501	0.064	CbGbCtD
Fesoterodine—ABCB1—Loratadine—atopic dermatitis	0.0367	0.0469	CbGbCtD
Fesoterodine—CYP2D6—Loratadine—atopic dermatitis	0.0345	0.0441	CbGbCtD
Fesoterodine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0345	0.0441	CbGbCtD
Fesoterodine—ABCB1—Methylprednisolone—atopic dermatitis	0.0335	0.0429	CbGbCtD
Fesoterodine—CYP3A4—Tacrolimus—atopic dermatitis	0.03	0.0384	CbGbCtD
Fesoterodine—CYP3A4—Loratadine—atopic dermatitis	0.022	0.0281	CbGbCtD
Fesoterodine—ABCB1—Betamethasone—atopic dermatitis	0.0218	0.0279	CbGbCtD
Fesoterodine—ABCB1—Prednisolone—atopic dermatitis	0.0215	0.0275	CbGbCtD
Fesoterodine—ABCB1—Hydrocortisone—atopic dermatitis	0.0204	0.0261	CbGbCtD
Fesoterodine—ABCB1—Prednisone—atopic dermatitis	0.0203	0.026	CbGbCtD
Fesoterodine—CYP3A4—Methylprednisolone—atopic dermatitis	0.0201	0.0257	CbGbCtD
Fesoterodine—CYP3A4—Triamcinolone—atopic dermatitis	0.0152	0.0195	CbGbCtD
Fesoterodine—CYP3A4—Betamethasone—atopic dermatitis	0.0131	0.0167	CbGbCtD
Fesoterodine—CYP3A4—Prednisolone—atopic dermatitis	0.0129	0.0165	CbGbCtD
Fesoterodine—ABCB1—Dexamethasone—atopic dermatitis	0.0127	0.0162	CbGbCtD
Fesoterodine—CYP3A4—Hydrocortisone—atopic dermatitis	0.0122	0.0156	CbGbCtD
Fesoterodine—CYP3A4—Prednisone—atopic dermatitis	0.0122	0.0156	CbGbCtD
Fesoterodine—CYP2D6—Dexamethasone—atopic dermatitis	0.0119	0.0153	CbGbCtD
Fesoterodine—CYP3A4—Dexamethasone—atopic dermatitis	0.0076	0.00971	CbGbCtD
Fesoterodine—Feeling abnormal—Loratadine—atopic dermatitis	0.000501	0.00247	CcSEcCtD
Fesoterodine—Dysgeusia—Tacrolimus—atopic dermatitis	0.000498	0.00246	CcSEcCtD
Fesoterodine—Rash—Dimenhydrinate—atopic dermatitis	0.000497	0.00245	CcSEcCtD
Fesoterodine—Rash—Diphenhydramine—atopic dermatitis	0.000497	0.00245	CcSEcCtD
Fesoterodine—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000497	0.00245	CcSEcCtD
Fesoterodine—Dermatitis—Diphenhydramine—atopic dermatitis	0.000497	0.00245	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000497	0.00245	CcSEcCtD
Fesoterodine—Dry skin—Prednisolone—atopic dermatitis	0.000494	0.00244	CcSEcCtD
Fesoterodine—Headache—Dimenhydrinate—atopic dermatitis	0.000494	0.00244	CcSEcCtD
Fesoterodine—Headache—Diphenhydramine—atopic dermatitis	0.000494	0.00244	CcSEcCtD
Fesoterodine—Back pain—Tacrolimus—atopic dermatitis	0.000492	0.00243	CcSEcCtD
Fesoterodine—Dry skin—Hydrocortisone—atopic dermatitis	0.000483	0.00238	CcSEcCtD
Fesoterodine—Abdominal pain upper—Hydrocortisone—atopic dermatitis	0.000481	0.00237	CcSEcCtD
Fesoterodine—Rash—Pimecrolimus—atopic dermatitis	0.000481	0.00237	CcSEcCtD
Fesoterodine—Dermatitis—Pimecrolimus—atopic dermatitis	0.00048	0.00237	CcSEcCtD
Fesoterodine—Abdominal pain—Loratadine—atopic dermatitis	0.00048	0.00237	CcSEcCtD
Fesoterodine—Vision blurred—Tacrolimus—atopic dermatitis	0.000479	0.00236	CcSEcCtD
Fesoterodine—Headache—Pimecrolimus—atopic dermatitis	0.000478	0.00236	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000471	0.00232	CcSEcCtD
Fesoterodine—Nausea—Dimenhydrinate—atopic dermatitis	0.000469	0.00231	CcSEcCtD
Fesoterodine—Nausea—Diphenhydramine—atopic dermatitis	0.000469	0.00231	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Hydrocortisone—atopic dermatitis	0.000465	0.00229	CcSEcCtD
Fesoterodine—Dyspepsia—Mometasone—atopic dermatitis	0.000459	0.00226	CcSEcCtD
Fesoterodine—Vertigo—Tacrolimus—atopic dermatitis	0.000457	0.00225	CcSEcCtD
Fesoterodine—Nausea—Pimecrolimus—atopic dermatitis	0.000453	0.00223	CcSEcCtD
Fesoterodine—Fatigue—Mometasone—atopic dermatitis	0.00045	0.00222	CcSEcCtD
Fesoterodine—Palpitations—Tacrolimus—atopic dermatitis	0.000449	0.00222	CcSEcCtD
Fesoterodine—Cough—Tacrolimus—atopic dermatitis	0.000444	0.00219	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Methylprednisolone—atopic dermatitis	0.000436	0.00215	CcSEcCtD
Fesoterodine—Asthenia—Loratadine—atopic dermatitis	0.000436	0.00215	CcSEcCtD
Fesoterodine—Chest pain—Tacrolimus—atopic dermatitis	0.000433	0.00213	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.00043	0.00212	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000426	0.0021	CcSEcCtD
Fesoterodine—Dry mouth—Tacrolimus—atopic dermatitis	0.000423	0.00209	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000423	0.00209	CcSEcCtD
Fesoterodine—Confusional state—Tacrolimus—atopic dermatitis	0.000418	0.00206	CcSEcCtD
Fesoterodine—Diarrhoea—Loratadine—atopic dermatitis	0.000416	0.00205	CcSEcCtD
Fesoterodine—Dry skin—Dexamethasone—atopic dermatitis	0.000412	0.00203	CcSEcCtD
Fesoterodine—Dry skin—Betamethasone—atopic dermatitis	0.000412	0.00203	CcSEcCtD
Fesoterodine—Infection—Tacrolimus—atopic dermatitis	0.000412	0.00203	CcSEcCtD
Fesoterodine—Abdominal pain—Mometasone—atopic dermatitis	0.000412	0.00203	CcSEcCtD
Fesoterodine—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000407	0.00201	CcSEcCtD
Fesoterodine—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000406	0.002	CcSEcCtD
Fesoterodine—Infestation—Hydrocortisone—atopic dermatitis	0.000406	0.002	CcSEcCtD
Fesoterodine—Tachycardia—Tacrolimus—atopic dermatitis	0.000405	0.002	CcSEcCtD
Fesoterodine—Skin disorder—Tacrolimus—atopic dermatitis	0.000403	0.00199	CcSEcCtD
Fesoterodine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000402	0.00198	CcSEcCtD
Fesoterodine—Dizziness—Loratadine—atopic dermatitis	0.000402	0.00198	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000398	0.00196	CcSEcCtD
Fesoterodine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000386	0.00191	CcSEcCtD
Fesoterodine—Rash—Loratadine—atopic dermatitis	0.000383	0.00189	CcSEcCtD
Fesoterodine—Dermatitis—Loratadine—atopic dermatitis	0.000383	0.00189	CcSEcCtD
Fesoterodine—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000381	0.00188	CcSEcCtD
Fesoterodine—Infestation—Methylprednisolone—atopic dermatitis	0.000381	0.00188	CcSEcCtD
Fesoterodine—Headache—Loratadine—atopic dermatitis	0.000381	0.00188	CcSEcCtD
Fesoterodine—Face oedema—Prednisone—atopic dermatitis	0.000378	0.00187	CcSEcCtD
Fesoterodine—Insomnia—Tacrolimus—atopic dermatitis	0.000375	0.00185	CcSEcCtD
Fesoterodine—Asthenia—Mometasone—atopic dermatitis	0.000374	0.00184	CcSEcCtD
Fesoterodine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000374	0.00184	CcSEcCtD
Fesoterodine—Somnolence—Tacrolimus—atopic dermatitis	0.000369	0.00182	CcSEcCtD
Fesoterodine—Pruritus—Mometasone—atopic dermatitis	0.000369	0.00182	CcSEcCtD
Fesoterodine—Dyspepsia—Tacrolimus—atopic dermatitis	0.000365	0.0018	CcSEcCtD
Fesoterodine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000361	0.00178	CcSEcCtD
Fesoterodine—Nausea—Loratadine—atopic dermatitis	0.000361	0.00178	CcSEcCtD
Fesoterodine—Dry skin—Prednisone—atopic dermatitis	0.000359	0.00177	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000358	0.00177	CcSEcCtD
Fesoterodine—Fatigue—Tacrolimus—atopic dermatitis	0.000358	0.00176	CcSEcCtD
Fesoterodine—Diarrhoea—Mometasone—atopic dermatitis	0.000357	0.00176	CcSEcCtD
Fesoterodine—Constipation—Tacrolimus—atopic dermatitis	0.000355	0.00175	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000346	0.0017	CcSEcCtD
Fesoterodine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000344	0.0017	CcSEcCtD
Fesoterodine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000344	0.0017	CcSEcCtD
Fesoterodine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000342	0.00169	CcSEcCtD
Fesoterodine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000342	0.00169	CcSEcCtD
Fesoterodine—Eye disorder—Hydrocortisone—atopic dermatitis	0.000341	0.00168	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000339	0.00167	CcSEcCtD
Fesoterodine—Urticaria—Tacrolimus—atopic dermatitis	0.00033	0.00163	CcSEcCtD
Fesoterodine—Rash—Mometasone—atopic dermatitis	0.000329	0.00162	CcSEcCtD
Fesoterodine—Dermatitis—Mometasone—atopic dermatitis	0.000328	0.00162	CcSEcCtD
Fesoterodine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000328	0.00162	CcSEcCtD
Fesoterodine—Headache—Mometasone—atopic dermatitis	0.000327	0.00161	CcSEcCtD
Fesoterodine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000324	0.0016	CcSEcCtD
Fesoterodine—Eye disorder—Methylprednisolone—atopic dermatitis	0.00032	0.00158	CcSEcCtD
Fesoterodine—Mental disorder—Hydrocortisone—atopic dermatitis	0.000319	0.00157	CcSEcCtD
Fesoterodine—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000318	0.00157	CcSEcCtD
Fesoterodine—Nausea—Mometasone—atopic dermatitis	0.00031	0.00153	CcSEcCtD
Fesoterodine—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000309	0.00152	CcSEcCtD
Fesoterodine—Vision blurred—Prednisolone—atopic dermatitis	0.000306	0.00151	CcSEcCtD
Fesoterodine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000306	0.00151	CcSEcCtD
Fesoterodine—Mental disorder—Methylprednisolone—atopic dermatitis	0.0003	0.00148	CcSEcCtD
Fesoterodine—Asthenia—Tacrolimus—atopic dermatitis	0.000298	0.00147	CcSEcCtD
Fesoterodine—Angioedema—Prednisolone—atopic dermatitis	0.000297	0.00146	CcSEcCtD
Fesoterodine—Pruritus—Tacrolimus—atopic dermatitis	0.000294	0.00145	CcSEcCtD
Fesoterodine—Dysgeusia—Triamcinolone—atopic dermatitis	0.000292	0.00144	CcSEcCtD
Fesoterodine—Vertigo—Prednisolone—atopic dermatitis	0.000292	0.00144	CcSEcCtD
Fesoterodine—Eye disorder—Dexamethasone—atopic dermatitis	0.000291	0.00143	CcSEcCtD
Fesoterodine—Eye disorder—Betamethasone—atopic dermatitis	0.000291	0.00143	CcSEcCtD
Fesoterodine—Angioedema—Hydrocortisone—atopic dermatitis	0.00029	0.00143	CcSEcCtD
Fesoterodine—Back pain—Triamcinolone—atopic dermatitis	0.000289	0.00142	CcSEcCtD
Fesoterodine—Vertigo—Hydrocortisone—atopic dermatitis	0.000285	0.00141	CcSEcCtD
Fesoterodine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000284	0.0014	CcSEcCtD
Fesoterodine—Dizziness—Tacrolimus—atopic dermatitis	0.000274	0.00135	CcSEcCtD
Fesoterodine—Angioedema—Triamcinolone—atopic dermatitis	0.000273	0.00135	CcSEcCtD
Fesoterodine—Angioedema—Methylprednisolone—atopic dermatitis	0.000272	0.00134	CcSEcCtD
Fesoterodine—Vertigo—Triamcinolone—atopic dermatitis	0.000268	0.00132	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000268	0.00132	CcSEcCtD
Fesoterodine—Vertigo—Methylprednisolone—atopic dermatitis	0.000268	0.00132	CcSEcCtD
Fesoterodine—Rash—Tacrolimus—atopic dermatitis	0.000262	0.00129	CcSEcCtD
Fesoterodine—Dermatitis—Tacrolimus—atopic dermatitis	0.000261	0.00129	CcSEcCtD
Fesoterodine—Cough—Triamcinolone—atopic dermatitis	0.000261	0.00129	CcSEcCtD
Fesoterodine—Headache—Tacrolimus—atopic dermatitis	0.00026	0.00128	CcSEcCtD
Fesoterodine—Tachycardia—Prednisolone—atopic dermatitis	0.000259	0.00128	CcSEcCtD
Fesoterodine—Infection—Hydrocortisone—atopic dermatitis	0.000257	0.00127	CcSEcCtD
Fesoterodine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000254	0.00125	CcSEcCtD
Fesoterodine—Eye disorder—Prednisone—atopic dermatitis	0.000253	0.00125	CcSEcCtD
Fesoterodine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000253	0.00125	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000252	0.00124	CcSEcCtD
Fesoterodine—Skin disorder—Hydrocortisone—atopic dermatitis	0.000251	0.00124	CcSEcCtD
Fesoterodine—Dry mouth—Triamcinolone—atopic dermatitis	0.000249	0.00123	CcSEcCtD
Fesoterodine—Angioedema—Dexamethasone—atopic dermatitis	0.000248	0.00122	CcSEcCtD
Fesoterodine—Angioedema—Betamethasone—atopic dermatitis	0.000248	0.00122	CcSEcCtD
Fesoterodine—Nausea—Tacrolimus—atopic dermatitis	0.000246	0.00122	CcSEcCtD
Fesoterodine—Confusional state—Methylprednisolone—atopic dermatitis	0.000245	0.00121	CcSEcCtD
Fesoterodine—Vertigo—Dexamethasone—atopic dermatitis	0.000243	0.0012	CcSEcCtD
Fesoterodine—Vertigo—Betamethasone—atopic dermatitis	0.000243	0.0012	CcSEcCtD
Fesoterodine—Infection—Triamcinolone—atopic dermatitis	0.000242	0.00119	CcSEcCtD
Fesoterodine—Infection—Methylprednisolone—atopic dermatitis	0.000242	0.00119	CcSEcCtD
Fesoterodine—Insomnia—Prednisolone—atopic dermatitis	0.00024	0.00118	CcSEcCtD
Fesoterodine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000239	0.00118	CcSEcCtD
Fesoterodine—Tachycardia—Triamcinolone—atopic dermatitis	0.000238	0.00117	CcSEcCtD
Fesoterodine—Mental disorder—Prednisone—atopic dermatitis	0.000238	0.00117	CcSEcCtD
Fesoterodine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000237	0.00117	CcSEcCtD
Fesoterodine—Skin disorder—Methylprednisolone—atopic dermatitis	0.000236	0.00116	CcSEcCtD
Fesoterodine—Insomnia—Hydrocortisone—atopic dermatitis	0.000234	0.00115	CcSEcCtD
Fesoterodine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000228	0.00112	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000223	0.0011	CcSEcCtD
Fesoterodine—Fatigue—Hydrocortisone—atopic dermatitis	0.000223	0.0011	CcSEcCtD
Fesoterodine—Vision blurred—Prednisone—atopic dermatitis	0.000222	0.0011	CcSEcCtD
Fesoterodine—Insomnia—Triamcinolone—atopic dermatitis	0.00022	0.00109	CcSEcCtD
Fesoterodine—Insomnia—Methylprednisolone—atopic dermatitis	0.00022	0.00108	CcSEcCtD
Fesoterodine—Infection—Dexamethasone—atopic dermatitis	0.00022	0.00108	CcSEcCtD
Fesoterodine—Infection—Betamethasone—atopic dermatitis	0.00022	0.00108	CcSEcCtD
Fesoterodine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000218	0.00108	CcSEcCtD
Fesoterodine—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000217	0.00107	CcSEcCtD
Fesoterodine—Nervous system disorder—Betamethasone—atopic dermatitis	0.000217	0.00107	CcSEcCtD
Fesoterodine—Tachycardia—Betamethasone—atopic dermatitis	0.000216	0.00106	CcSEcCtD
Fesoterodine—Tachycardia—Dexamethasone—atopic dermatitis	0.000216	0.00106	CcSEcCtD
Fesoterodine—Angioedema—Prednisone—atopic dermatitis	0.000216	0.00106	CcSEcCtD
Fesoterodine—Dyspepsia—Triamcinolone—atopic dermatitis	0.000215	0.00106	CcSEcCtD
Fesoterodine—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000214	0.00106	CcSEcCtD
Fesoterodine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000213	0.00105	CcSEcCtD
Fesoterodine—Vertigo—Prednisone—atopic dermatitis	0.000212	0.00105	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000212	0.00104	CcSEcCtD
Fesoterodine—Urticaria—Prednisolone—atopic dermatitis	0.000211	0.00104	CcSEcCtD
Fesoterodine—Fatigue—Triamcinolone—atopic dermatitis	0.00021	0.00104	CcSEcCtD
Fesoterodine—Fatigue—Methylprednisolone—atopic dermatitis	0.00021	0.00103	CcSEcCtD
Fesoterodine—Urticaria—Hydrocortisone—atopic dermatitis	0.000206	0.00101	CcSEcCtD
Fesoterodine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000205	0.00101	CcSEcCtD
Fesoterodine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000201	0.000991	CcSEcCtD
Fesoterodine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.0002	0.000988	CcSEcCtD
Fesoterodine—Insomnia—Betamethasone—atopic dermatitis	0.0002	0.000986	CcSEcCtD
Fesoterodine—Insomnia—Dexamethasone—atopic dermatitis	0.0002	0.000986	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.0002	0.000984	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000199	0.000981	CcSEcCtD
Fesoterodine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000195	0.000963	CcSEcCtD
Fesoterodine—Dyspepsia—Dexamethasone—atopic dermatitis	0.000195	0.00096	CcSEcCtD
Fesoterodine—Dyspepsia—Betamethasone—atopic dermatitis	0.000195	0.00096	CcSEcCtD
Fesoterodine—Urticaria—Triamcinolone—atopic dermatitis	0.000194	0.000955	CcSEcCtD
Fesoterodine—Urticaria—Methylprednisolone—atopic dermatitis	0.000193	0.000953	CcSEcCtD
Fesoterodine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000192	0.000948	CcSEcCtD
Fesoterodine—Infection—Prednisone—atopic dermatitis	0.000191	0.000944	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000191	0.000942	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000191	0.000942	CcSEcCtD
Fesoterodine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000191	0.000941	CcSEcCtD
Fesoterodine—Fatigue—Dexamethasone—atopic dermatitis	0.000191	0.00094	CcSEcCtD
Fesoterodine—Fatigue—Betamethasone—atopic dermatitis	0.000191	0.00094	CcSEcCtD
Fesoterodine—Nervous system disorder—Prednisone—atopic dermatitis	0.000189	0.000931	CcSEcCtD
Fesoterodine—Tachycardia—Prednisone—atopic dermatitis	0.000188	0.000927	CcSEcCtD
Fesoterodine—Skin disorder—Prednisone—atopic dermatitis	0.000187	0.000923	CcSEcCtD
Fesoterodine—Asthenia—Hydrocortisone—atopic dermatitis	0.000186	0.000916	CcSEcCtD
Fesoterodine—Pruritus—Hydrocortisone—atopic dermatitis	0.000183	0.000903	CcSEcCtD
Fesoterodine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000182	0.000899	CcSEcCtD
Fesoterodine—Feeling abnormal—Betamethasone—atopic dermatitis	0.000182	0.000899	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000181	0.000892	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000181	0.000892	CcSEcCtD
Fesoterodine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.00018	0.000886	CcSEcCtD
Fesoterodine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000179	0.000884	CcSEcCtD
Fesoterodine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000177	0.000873	CcSEcCtD
Fesoterodine—Urticaria—Dexamethasone—atopic dermatitis	0.000176	0.000866	CcSEcCtD
Fesoterodine—Urticaria—Betamethasone—atopic dermatitis	0.000176	0.000866	CcSEcCtD
Fesoterodine—Dizziness—Prednisolone—atopic dermatitis	0.000175	0.000864	CcSEcCtD
Fesoterodine—Asthenia—Triamcinolone—atopic dermatitis	0.000175	0.000862	CcSEcCtD
Fesoterodine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000175	0.000862	CcSEcCtD
Fesoterodine—Abdominal pain—Betamethasone—atopic dermatitis	0.000175	0.000862	CcSEcCtD
Fesoterodine—Asthenia—Methylprednisolone—atopic dermatitis	0.000174	0.00086	CcSEcCtD
Fesoterodine—Insomnia—Prednisone—atopic dermatitis	0.000174	0.000859	CcSEcCtD
Fesoterodine—Pruritus—Triamcinolone—atopic dermatitis	0.000172	0.00085	CcSEcCtD
Fesoterodine—Pruritus—Methylprednisolone—atopic dermatitis	0.000172	0.000849	CcSEcCtD
Fesoterodine—Dizziness—Hydrocortisone—atopic dermatitis	0.000171	0.000844	CcSEcCtD
Fesoterodine—Dyspepsia—Prednisone—atopic dermatitis	0.00017	0.000836	CcSEcCtD
Fesoterodine—Rash—Prednisolone—atopic dermatitis	0.000167	0.000824	CcSEcCtD
Fesoterodine—Dermatitis—Prednisolone—atopic dermatitis	0.000167	0.000823	CcSEcCtD
Fesoterodine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000166	0.000821	CcSEcCtD
Fesoterodine—Fatigue—Prednisone—atopic dermatitis	0.000166	0.000819	CcSEcCtD
Fesoterodine—Headache—Prednisolone—atopic dermatitis	0.000166	0.000819	CcSEcCtD
Fesoterodine—Constipation—Prednisone—atopic dermatitis	0.000165	0.000812	CcSEcCtD
Fesoterodine—Rash—Hydrocortisone—atopic dermatitis	0.000163	0.000805	CcSEcCtD
Fesoterodine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000163	0.000804	CcSEcCtD
Fesoterodine—Headache—Hydrocortisone—atopic dermatitis	0.000162	0.0008	CcSEcCtD
Fesoterodine—Dizziness—Triamcinolone—atopic dermatitis	0.000161	0.000795	CcSEcCtD
Fesoterodine—Dizziness—Methylprednisolone—atopic dermatitis	0.000161	0.000793	CcSEcCtD
Fesoterodine—Feeling abnormal—Prednisone—atopic dermatitis	0.000159	0.000783	CcSEcCtD
Fesoterodine—Asthenia—Dexamethasone—atopic dermatitis	0.000159	0.000783	CcSEcCtD
Fesoterodine—Asthenia—Betamethasone—atopic dermatitis	0.000159	0.000783	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000157	0.000777	CcSEcCtD
Fesoterodine—Nausea—Prednisolone—atopic dermatitis	0.000157	0.000776	CcSEcCtD
Fesoterodine—Pruritus—Betamethasone—atopic dermatitis	0.000156	0.000772	CcSEcCtD
Fesoterodine—Pruritus—Dexamethasone—atopic dermatitis	0.000156	0.000772	CcSEcCtD
Fesoterodine—Nausea—Hydrocortisone—atopic dermatitis	0.000154	0.000758	CcSEcCtD
Fesoterodine—Rash—Triamcinolone—atopic dermatitis	0.000154	0.000758	CcSEcCtD
Fesoterodine—Dermatitis—Triamcinolone—atopic dermatitis	0.000154	0.000757	CcSEcCtD
Fesoterodine—Rash—Methylprednisolone—atopic dermatitis	0.000153	0.000756	CcSEcCtD
Fesoterodine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000153	0.000756	CcSEcCtD
Fesoterodine—Urticaria—Prednisone—atopic dermatitis	0.000153	0.000755	CcSEcCtD
Fesoterodine—Headache—Triamcinolone—atopic dermatitis	0.000153	0.000753	CcSEcCtD
Fesoterodine—Headache—Methylprednisolone—atopic dermatitis	0.000152	0.000751	CcSEcCtD
Fesoterodine—Abdominal pain—Prednisone—atopic dermatitis	0.000152	0.000751	CcSEcCtD
Fesoterodine—Diarrhoea—Dexamethasone—atopic dermatitis	0.000151	0.000746	CcSEcCtD
Fesoterodine—Diarrhoea—Betamethasone—atopic dermatitis	0.000151	0.000746	CcSEcCtD
Fesoterodine—Dizziness—Dexamethasone—atopic dermatitis	0.000146	0.000721	CcSEcCtD
Fesoterodine—Dizziness—Betamethasone—atopic dermatitis	0.000146	0.000721	CcSEcCtD
Fesoterodine—Nausea—Triamcinolone—atopic dermatitis	0.000145	0.000714	CcSEcCtD
Fesoterodine—Nausea—Methylprednisolone—atopic dermatitis	0.000144	0.000712	CcSEcCtD
Fesoterodine—Hypersensitivity—Prednisone—atopic dermatitis	0.000142	0.0007	CcSEcCtD
Fesoterodine—Rash—Betamethasone—atopic dermatitis	0.000139	0.000688	CcSEcCtD
Fesoterodine—Rash—Dexamethasone—atopic dermatitis	0.000139	0.000688	CcSEcCtD
Fesoterodine—Dermatitis—Dexamethasone—atopic dermatitis	0.000139	0.000687	CcSEcCtD
Fesoterodine—Dermatitis—Betamethasone—atopic dermatitis	0.000139	0.000687	CcSEcCtD
Fesoterodine—Headache—Betamethasone—atopic dermatitis	0.000139	0.000683	CcSEcCtD
Fesoterodine—Headache—Dexamethasone—atopic dermatitis	0.000139	0.000683	CcSEcCtD
Fesoterodine—Asthenia—Prednisone—atopic dermatitis	0.000138	0.000681	CcSEcCtD
Fesoterodine—Pruritus—Prednisone—atopic dermatitis	0.000136	0.000672	CcSEcCtD
Fesoterodine—Diarrhoea—Prednisone—atopic dermatitis	0.000132	0.00065	CcSEcCtD
Fesoterodine—Nausea—Dexamethasone—atopic dermatitis	0.000131	0.000648	CcSEcCtD
Fesoterodine—Nausea—Betamethasone—atopic dermatitis	0.000131	0.000648	CcSEcCtD
Fesoterodine—Dizziness—Prednisone—atopic dermatitis	0.000127	0.000628	CcSEcCtD
Fesoterodine—Rash—Prednisone—atopic dermatitis	0.000121	0.000599	CcSEcCtD
Fesoterodine—Dermatitis—Prednisone—atopic dermatitis	0.000121	0.000598	CcSEcCtD
Fesoterodine—Headache—Prednisone—atopic dermatitis	0.000121	0.000595	CcSEcCtD
Fesoterodine—Nausea—Prednisone—atopic dermatitis	0.000114	0.000564	CcSEcCtD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.62e-05	0.00177	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	2.6e-05	0.00176	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	2.59e-05	0.00176	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—CXCR3—atopic dermatitis	2.58e-05	0.00175	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	2.57e-05	0.00174	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—IL5—atopic dermatitis	2.56e-05	0.00173	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCL17—atopic dermatitis	2.52e-05	0.00171	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—TAC1—atopic dermatitis	2.5e-05	0.00169	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—NPS—atopic dermatitis	2.5e-05	0.00169	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—CXCR3—atopic dermatitis	2.45e-05	0.00166	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—IL5—atopic dermatitis	2.45e-05	0.00166	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCL17—atopic dermatitis	2.41e-05	0.00163	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—TAC1—atopic dermatitis	2.39e-05	0.00162	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—NPS—atopic dermatitis	2.39e-05	0.00162	CbGpPWpGaD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.38e-05	0.00161	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—CXCR3—atopic dermatitis	2.35e-05	0.00159	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL5—atopic dermatitis	2.32e-05	0.00157	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	2.32e-05	0.00157	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	2.31e-05	0.00157	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	2.29e-05	0.00155	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	2.29e-05	0.00155	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	2.28e-05	0.00154	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.28e-05	0.00154	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	2.26e-05	0.00153	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—KIF3A—atopic dermatitis	2.25e-05	0.00152	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	2.24e-05	0.00152	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	2.23e-05	0.00151	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL5—atopic dermatitis	2.23e-05	0.00151	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	2.21e-05	0.0015	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—CXCL10—atopic dermatitis	2.18e-05	0.00148	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GLB1—atopic dermatitis	2.16e-05	0.00146	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—KIF3A—atopic dermatitis	2.15e-05	0.00146	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	2.13e-05	0.00144	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.12e-05	0.00144	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	2.12e-05	0.00143	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.11e-05	0.00143	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	2.1e-05	0.00142	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—CXCL10—atopic dermatitis	2.09e-05	0.00141	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	2.08e-05	0.00141	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	2.08e-05	0.00141	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ADSL—atopic dermatitis	2.07e-05	0.0014	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	2.06e-05	0.00139	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCL11—atopic dermatitis	2.03e-05	0.00138	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CMA1—atopic dermatitis	2.03e-05	0.00138	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	2.02e-05	0.00137	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	2.01e-05	0.00136	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	2.01e-05	0.00136	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	1.99e-05	0.00135	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.99e-05	0.00135	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—CXCL10—atopic dermatitis	1.98e-05	0.00134	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.96e-05	0.00132	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CMA1—atopic dermatitis	1.95e-05	0.00132	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCL11—atopic dermatitis	1.95e-05	0.00132	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	1.92e-05	0.0013	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—STAT6—atopic dermatitis	1.91e-05	0.00129	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	1.9e-05	0.00129	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	1.9e-05	0.00128	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	1.9e-05	0.00128	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	1.89e-05	0.00128	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	1.89e-05	0.00128	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	1.88e-05	0.00128	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	1.88e-05	0.00127	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	1.87e-05	0.00127	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	1.87e-05	0.00126	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	1.86e-05	0.00126	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	1.86e-05	0.00126	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	1.85e-05	0.00125	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	1.85e-05	0.00125	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	1.83e-05	0.00124	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	1.83e-05	0.00124	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	1.83e-05	0.00124	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.82e-05	0.00123	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	1.81e-05	0.00123	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	1.81e-05	0.00123	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	1.8e-05	0.00122	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	1.8e-05	0.00122	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	1.73e-05	0.00117	CbGpPWpGaD
Fesoterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.73e-05	0.00117	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	1.73e-05	0.00117	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	1.72e-05	0.00116	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	1.71e-05	0.00115	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	1.7e-05	0.00115	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	1.7e-05	0.00115	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	1.69e-05	0.00115	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	1.69e-05	0.00115	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	1.69e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	1.69e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	1.68e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	1.68e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	1.68e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	1.66e-05	0.00113	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	1.66e-05	0.00113	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	1.66e-05	0.00112	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	1.65e-05	0.00112	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	1.65e-05	0.00112	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	1.63e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	1.63e-05	0.0011	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	1.62e-05	0.0011	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.6e-05	0.00109	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.6e-05	0.00108	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	1.59e-05	0.00107	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.58e-05	0.00107	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	1.57e-05	0.00106	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	1.56e-05	0.00106	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.55e-05	0.00105	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	1.55e-05	0.00105	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	1.54e-05	0.00104	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	1.52e-05	0.00103	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	1.51e-05	0.00102	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	1.5e-05	0.00101	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NPS—atopic dermatitis	1.48e-05	0.001	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	1.48e-05	0.001	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	1.47e-05	0.000996	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.47e-05	0.000996	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	1.47e-05	0.000993	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	1.45e-05	0.000983	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	1.45e-05	0.00098	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	1.41e-05	0.000957	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NPS—atopic dermatitis	1.41e-05	0.000957	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	1.39e-05	0.000939	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL5—atopic dermatitis	1.37e-05	0.000929	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	1.37e-05	0.000928	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	1.37e-05	0.000928	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GLB1—atopic dermatitis	1.37e-05	0.000926	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	1.37e-05	0.000925	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	1.37e-05	0.000925	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	1.35e-05	0.000916	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	1.35e-05	0.000916	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	1.34e-05	0.000904	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	1.33e-05	0.000901	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.32e-05	0.000896	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	1.32e-05	0.000893	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL5—atopic dermatitis	1.31e-05	0.00089	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ADSL—atopic dermatitis	1.31e-05	0.000888	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.29e-05	0.000872	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	1.29e-05	0.000872	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	1.28e-05	0.000869	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	1.28e-05	0.000869	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	1.27e-05	0.000861	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	1.27e-05	0.000857	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	1.26e-05	0.000855	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	1.25e-05	0.000846	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.24e-05	0.000836	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	1.22e-05	0.000826	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	1.22e-05	0.000824	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.22e-05	0.000823	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.21e-05	0.00082	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	1.2e-05	0.000816	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	1.17e-05	0.000792	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	1.15e-05	0.000778	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	1.15e-05	0.000776	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	1.14e-05	0.000772	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	1.14e-05	0.00077	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	1.14e-05	0.000768	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	1.13e-05	0.000762	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	1.12e-05	0.000759	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	1.12e-05	0.000756	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	1.11e-05	0.000754	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	1.1e-05	0.000746	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.05e-05	0.000709	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	1.04e-05	0.000701	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	1.03e-05	0.000699	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	1.02e-05	0.000692	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	1.02e-05	0.000692	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	1.01e-05	0.000682	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	9.96e-06	0.000674	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NPS—atopic dermatitis	9.96e-06	0.000674	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	9.92e-06	0.000672	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NPS—atopic dermatitis	9.92e-06	0.000672	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	9.83e-06	0.000665	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NPS—atopic dermatitis	9.83e-06	0.000665	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	9.8e-06	0.000663	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	9.78e-06	0.000662	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	9.76e-06	0.000661	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	9.73e-06	0.000659	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	9.65e-06	0.000653	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	9.64e-06	0.000652	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.48e-06	0.000641	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	9.36e-06	0.000634	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NGF—atopic dermatitis	9.33e-06	0.000632	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	9.29e-06	0.000629	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL5—atopic dermatitis	9.26e-06	0.000627	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL5—atopic dermatitis	9.23e-06	0.000625	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL5—atopic dermatitis	9.14e-06	0.000618	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	9.08e-06	0.000614	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NGF—atopic dermatitis	8.94e-06	0.000605	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	8.9e-06	0.000602	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	8.88e-06	0.000601	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	8.69e-06	0.000588	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	8.5e-06	0.000576	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GLB1—atopic dermatitis	8.43e-06	0.00057	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ADSL—atopic dermatitis	8.08e-06	0.000547	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	7.89e-06	0.000534	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	7.87e-06	0.000533	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	7.79e-06	0.000527	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	7.69e-06	0.000521	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	7.37e-06	0.000499	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PPARA—atopic dermatitis	6.99e-06	0.000474	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	6.9e-06	0.000467	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	6.88e-06	0.000465	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	6.81e-06	0.000461	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	6.79e-06	0.00046	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	6.77e-06	0.000458	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	6.71e-06	0.000454	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	6.59e-06	0.000446	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	6.57e-06	0.000445	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	6.51e-06	0.00044	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	6.29e-06	0.000426	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NGF—atopic dermatitis	6.27e-06	0.000425	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	6.26e-06	0.000424	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	6.24e-06	0.000423	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NGF—atopic dermatitis	6.21e-06	0.00042	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	6.18e-06	0.000419	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	6.12e-06	0.000414	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	6.1e-06	0.000413	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	6.04e-06	0.000409	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	5.99e-06	0.000405	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	5.97e-06	0.000404	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	5.91e-06	0.0004	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	5.49e-06	0.000371	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	5.25e-06	0.000356	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL2—atopic dermatitis	5.24e-06	0.000355	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	5.22e-06	0.000353	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	5.19e-06	0.000351	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	5.17e-06	0.00035	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	5.12e-06	0.000347	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL2—atopic dermatitis	5.02e-06	0.00034	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	5e-06	0.000338	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	4.83e-06	0.000327	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	4.62e-06	0.000313	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARA—atopic dermatitis	4.44e-06	0.0003	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARA—atopic dermatitis	4.18e-06	0.000283	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	3.7e-06	0.00025	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	3.69e-06	0.00025	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	3.65e-06	0.000247	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	3.54e-06	0.000239	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL2—atopic dermatitis	3.52e-06	0.000239	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	3.52e-06	0.000238	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	3.51e-06	0.000237	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL2—atopic dermatitis	3.49e-06	0.000236	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	3.47e-06	0.000235	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	3.25e-06	0.00022	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	3.24e-06	0.00022	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	3.21e-06	0.000218	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—atopic dermatitis	3.08e-06	0.000209	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—atopic dermatitis	2.95e-06	0.0002	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.73e-06	0.000185	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	2.08e-06	0.000141	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—atopic dermatitis	2.07e-06	0.00014	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—atopic dermatitis	2.05e-06	0.000139	CbGpPWpGaD
